Home » Market News » DirectorsTalk Highlights » Executive interview – Avacta Group – Healthcare
Avacta Group Plc

Executive interview – Avacta Group – Healthcare

In this video, Alastair Smith, CEO of Avacta Group (LON:AVCT), discusses the progress the company has made this year. This includes new and expanded partnerships, operational and financial achievements, and the advancement of AVA6000 towards the clinic.

Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.